Olanzapine compositions and methods of use
US12220418B2 · kind B2 · utility
0Cited by
3References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2024 |
| Grant date | Feb 11, 2025 |
| Priority date | — |
| Expiry date | Jun 7, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides pharmaceutical compositions for subcutaneous administration comprising olanzapine, and organic solvent, and a triblock copolymer, and a diblock copolymer, as well as methods of treating psychiatric diseases and disorders using such compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.